Gratitude Journaling: Notes & Benefits
- We often operate in a cycle of reactive healthcare, addressing symptoms onyl when they become urgent.
- When facing unexpected health challenges - such as breast cancer - reclaiming control of our health journey through informed and proactive care is paramount.Kisqali (ribociclib) has been a...
- About Kisqali: Kisqali is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor.CDK4/6 proteins promote cancer cell growth.
“`html
Proactive Breast Cancer Care: Reclaiming Time and Understanding Evolving Options
Table of Contents
The Shift to Reactive Healthcare
We often operate in a cycle of reactive healthcare, addressing symptoms onyl when they become urgent. Rather of consistent check-ins, we tend to wait until subtle warning signs escalate into full-blown crises requiring immediate, intensive intervention. This pattern isn’t unique to any single illness, but it’s particularly critical to address when it comes to potentially life-threatening conditions.
Breast Cancer and the Importance of Proactive Care
When facing unexpected health challenges – such as breast cancer – reclaiming control of our health journey through informed and proactive care is paramount.Kisqali (ribociclib) has been a support for patients wiht metastatic breast cancer for some time, and has recently expanded its role as a treatment option for early-stage breast cancer, offering data-backed results that aim to reduce the risk of recurrence.
Targeted Therapy and Positive Outcomes
Targeted therapy approaches, like those utilizing kisqali, are demonstrating measurable progress in breast cancer treatment. Studies have shown that when certain treatments are used in combination with an aromatase inhibitor (AI),a remarkable 91% of patients remained cancer-free after three years. This data, published in the New England Journal of medicine in 2023, highlights the advancements being made and underscores the importance of staying informed about evolving treatment options. Read the full study.
Aromatase inhibitors (AIs) work by blocking the enzyme aromatase, wich the body uses to make estrogen. Since many breast cancers are fueled by estrogen, AIs can help slow or stop their growth. Combining AIs with targeted therapies like Kisqali can enhance their effectiveness.
Early Detection and Listening to Your Body
While early detection remains the most critically important factor in achieving positive outcomes, continuous learning and increased awareness are equally vital. Listening closely to our bodies and recognizing subtle changes can empower us to seek timely medical attention. Innovations in treatment and increased awareness are expanding access to the knowledge, support, and care that everyone deserves.
Key Symptoms to Watch For:
- A new lump or thickening in the breast or underarm area
- Changes in the size or shape of the breast
- nipple discharge (other than breast milk)
- inverted nipple
- Changes in the skin of the breast, such as dimpling or redness
- Pain in the breast that doesn’t go away
It’s vital to note that these symptoms can also be caused by non-cancerous conditions, but it’s always best to consult a healthcare professional to rule out any potential concerns.
Disparities in Breast Cancer Care
It’s crucial to acknowledge that breast cancer disproportionately affects Black women. According to the American cancer Society, Black women are 40% more likely to die from breast cancer than White women. This disparity is often linked to factors such
